Replies to post #235683 on Biotech Values

[DewDiligence]

BCLI -32% on negative FDA feedback re ALS program:

https://finance.yahoo.com/news/brainstorm-announces-high-level-fda-130500410.html

Why were investors expecting a different outcome?